Kirk V. Shepard
À propos de l'auteur
Dr. KIRK SHEPARD , a board-certified oncologist and hematologist, has led pharmaceutical innovation for over thirty years, including roles at Boehringer Ingelheim, Takeda, and Eisai. Currently CMO at PDS Biotechnology, his expertise spans all phases of drug development and commercialization. In 2015, PharmaVoice named him among the 100 Most Inspiring People in Pharma. He also cofounded the Medical Affairs Professional Society (MAPS) and co-edited Medical Affairs (2024).
Voices of Oncology
Fostering a Collaborative Community of Experts to Accelerate Cancer Cures
Kirk V. Shepard, Ramin Farhood